Of note, pancreatic carcinoma cells constitutively express LIF and its heterodimer receptor (LIFR and gp130), and TNFα, IL1β or LIF itself enhanced the expression of LIF mRNA. The gene discussed is LIF; the disease is exocrine pancreatic carcinoma.